Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
Irene Kuter(Boston University), Julia M.W. Gee(Cardiff University), Roberto Hegg(Hospital Pérola Byington), Christian F. Singer(Medical University of Vienna), Rajendra Badwe(Tata Memorial Hospital), Elizabeth Lowe(AstraZeneca (United States)), Ugochi Emeribe(AstraZeneca (United States)), Elizabeth J. Anderson(AstraZeneca (United Kingdom)), Francisco Sapunar(AstraZeneca (United Kingdom)), Pauline Finlay(Tenovus Cancer Care), Robert I. Nicholson(Tenovus Cancer Care), José Bines(Instituto Nacional do Câncer), Nadia Harbeck(Klinikum rechts der Isar)
Cited by 99
Abstract
Related Papers
No related papers found
Powered by citation graph analysis